75 percent of those at high risk for BRCA mutations have no idea they may have increased chance of ovarian cancer, drawing attention to the importance of genetic counseling.
Any woman who’s watched her mother or sister struggle with breast cancer knows that she’s likely at high risk for the disease herself. But what she probably doesn’t realize is that she may have an increased chance of ovarian cancer as well, according to a new study by Fred Hutchinson Cancer Research Center scientists.
In an analysis of nearly 1,900 Seattle-area women with family histories that could suggest dangerous BRCA1 or BRCA2 genetic mutations that raise cancer risk, nearly two-thirds of those surveyed knew they should be worried about breast cancer — but more than 75 percent had no idea they should be concerned about ovarian cancer as well.
Those were startling findings to Dr. Robyn Andersen, an expert in ovarian cancer symptoms and screening in Fred Hutch’s Public Health Sciences division. She found that in the more than 15 years since BRCA testing has been available, awareness among high-risk women of ovarian cancer hadn’t budged, even though the American Cancer Society estimates the disease will be diagnosed in nearly 22,000 U.S women this year and will kill more than 14,000.
Read the new here: http://bit.ly/1q32Sca
Source: Fred Hutchison Cancer Research Center
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy
December 16th 2025The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.
Read More